SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tunica Albuginea who wrote (6038)3/21/1998 2:00:00 PM
From: east  Read Replies (3) of 23519
 
I just Emailed this to 20/20, and ABC...I think we all should send them an Email
and demand correction...
Email Address: abcnews.com
<<Respectfully,
I watched your 20/20 news about ED...I used to have a great respect
for your show, I almost watch every Friday night your show...
but by seeing the infomercial news by Pfizer on your report
without any one on your show editing, auditing, etc.
I doubt I will be watching your show any longer...
I think it was demeaning for ABC, and 20/20 to air the Pfizer
infomercial, without someone check, and editting them properly...
For your information there has been a drug out there which revolutionized
ED market from early 1997, it is called MUSE, by a company called VIVUS, INC.
I think your report lacks integrity, by not mentioning this drug
even one time, (although other small competitors to viagra mentioned)...
I think 20/20 got abused by this pfizer infomercial, and if I don't hear a correction in the next
show about existing drug (MUSE) currently in the market, and best seller ED thrapy
for millions of impotent ment, I will no longer watch your show,
and I encourage everyone not to watch this used to be great reporting media by
allowing to be a forum for big pharmacuetical company as a infomercial...
God Bless>>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext